Literature DB >> 28225340

Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.

A Javaid1, R Hasan2, A Zafar2, M A Chaudry3, S Qayyum4, E Qadeer5, Z Shaheen6, N Agha7, N Rizvi8, M Z Afridi9, M K Chima10, A R Khan11, A Ghafoor12, S Khan13, S R Awan14, S Akhtar15, K Choudry16, Z H Iqbal17, M Ansarie18, N Ahmad19.   

Abstract

BACKGROUND: Drug resistance in general, and multidrug-resistant tuberculosis (MDR-TB) in particular, threatens global tuberculosis (TB) control efforts. Population-based estimates of drug resistance are needed to develop strategies for controlling drug-resistant TB in Pakistan.
OBJECTIVE: To obtain population-based data on Mycobacterium tuberculosis drug resistance in Pakistan.
METHODS: To obtain drug resistance data, we conducted a population-based study of TB cases in all provinces of Pakistan. We performed culture and drug susceptibility testing on M. tuberculosis isolates from patients with a prior history of anti-tuberculosis treatment (retreatment cases) from all over the country.
RESULTS: Of 544 isolates from previously treated cases, 289 (53.1%) were susceptible to all first-line drugs, 255 (46.9%) were resistant to at least one anti-tuberculosis drug and 132 (24.3%) were MDR-TB. Among MDR-TB isolates, 47.0% were ofloxacin (OFX) resistant. Extensively drug-resistant TB was found in two (0.4%) isolates.
CONCLUSION: Prevalence of drug resistance in retreatment isolates was high. The alarmingly high prevalence of OFX resistance among MDR-TB isolates may threaten the success of efforts to control and treat MDR-TB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28225340     DOI: 10.5588/ijtld.16.0444

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  The epidemiology of drug-resistant tuberculosis in Bulawayo and Matabeleland South provinces, Zimbabwe 2017.

Authors:  Hamufare Mugauri Dumisani; Joconiah Chirenda; Tsitsi Juru; Owen Mugurungi; Gerald Shambira; Notion Gombe; Mufuta Tshimanga
Journal:  IJID Reg       Date:  2022-03-10

2.  Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country.

Authors:  Abdul Wahid; Abdul Ghafoor; Abdul Wali Khan; Yaser Mohammed Al-Worafi; Abdullah Latif; Nisar Ahmed Shahwani; Muhammad Atif; Fahad Saleem; Nafees Ahmad
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

3.  Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.

Authors:  Muhammad Atif; Arslan Bashir; Nafees Ahmad; Razia Kaneez Fatima; Sehar Saba; Shane Scahill
Journal:  BMC Infect Dis       Date:  2017-09-29       Impact factor: 3.090

4.  Tuberculosis among Full-Time Teachers in Southeast China, 2005⁻2016.

Authors:  Hongdan Bao; Kui Liu; Zikang Wu; Chengliang Chai; Tieniu He; Wei Wang; Fei Wang; Ying Peng; Xiaomeng Wang; Bin Chen; Jianmin Jiang
Journal:  Int J Environ Res Public Health       Date:  2018-09-17       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.